Why the study?
The study aimed to investigate the association between increased ACE2 levels and cardiovascular risk in patients with type 2 diabetes mellitus, particularly those with cardiovascular disease.
Are increased ACE2 levels associated with cardiovascular risk in patients with type 2 diabetes mellitus?
Population
3 groups of 87 individuals each (controls, diabetes, and diabetes with heart disease)
Comparison
Controls vs diabetes vs diabetes with heart disease
Design
Cross-sectional study
Authors
Loading...
Higher ACE2 may flag CV risk in T2DM; hypothesis-generating and requires prospective validation before any clinical role.
Are increased ACE2 levels associated with cardiovascular risk in patients with type 2 diabetes mellitus?
Increased ACE2 levels are strongly associated with inflammatory and lipid biomarkers in patients with type 2 diabetes and heart disease, suggesting its potential utility for independent cardiovascular risk assessment.
Naveena et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: